Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MICROLET®NEXT 2 Lancing Device

K-Number: K250813 · 2025-05-14

Decision Date2025-05-14
Product CodeQRL
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

MICROLET®NEXT 2 Lancing Device is the device name listed in this FDA 510(k) record. The listed applicant is Ascensia Diabetes Care U.S., Inc.. It received FDA 510(k) clearance on 2025-05-14 under 510(k) number K250813. The device is classified under product code QRL. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MICROLET®NEXT 2 Lancing Device?

MICROLET®NEXT 2 Lancing Device is a medical device that received FDA 510(k) clearance on 2025-05-14. The listed applicant is Ascensia Diabetes Care U.S., Inc.. The 510(k) number is K250813.

When did MICROLET®NEXT 2 Lancing Device receive FDA 510(k) clearance?

MICROLET®NEXT 2 Lancing Device received FDA 510(k) clearance on 2025-05-14, under 510(k) number K250813.

Who is the listed applicant for MICROLET®NEXT 2 Lancing Device?

The FDA 510(k) record lists Ascensia Diabetes Care U.S., Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for MICROLET®NEXT 2 Lancing Device?

The FDA product code for MICROLET®NEXT 2 Lancing Device is QRL.

Other records listing Ascensia Diabetes Care U.S., Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 7 devices →

Related Devices (Code: QRL)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.